Appointment
Linda Summerton, @ Immodulon

One Nucleus: Seasoned Director

One Nucleus, the Cambridge-based not-for-profit membership organisation for international life science and healthcare companies, announced the appointment of Linda Summerton as a Director. Summerton is Chief Executive of Immodulon and a Senior Partner with TranScrip Partners.

Summerton has over 25 years’ experience in the global pharmaceutical industry in large pharmaceutical companies, small biotechnology companies, private equity ventures and specialist service provider organisations. For 18 years, she worked at AstraZeneca, where she held a variety of roles, most recently Head of Strategy and Portfolio for the Oncology and Infection Therapy Area Management Team. She has a first degree and PhD from Cambridge UK, and held a NATO post-doctoral Fellowship tenured at University of California, San Francisco.